2019 LMG Life Sciences research has officially begun!
March 22, 2019
Now accepting firm surveys and partner interviews
US
General Patent Litigation
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Chu, Morgan | Intellectual Property | General Patent Litigation | Los Angeles |
| Gindler, David | Intellectual Property | General Patent Litigation, Patent Strategy & Management | Los Angeles |
| Sheasby, Jason G | Intellectual Property | General Patent Litigation, Hatch-Waxman Patent Litigation | Los Angeles |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Intellectual Property
Irell & Manella
Irell & Manella continues to be a patent litigation powerhouse in the life sciences space, helming litigations involving sophisticated technologies for companies small and large. Most notably, the firm is a significant player in patent disputes related to biologics, with an expanding book of clients in the area. A peer praises Irell's litigation team over its competitors, saying they have a "deeper understanding of the law, dig into the facts more and are better strategic thinkers."
Morgan Chu is one of the most celebrated patent litigators in the country, and remains a leader in the firm's practice. He currently serves as chair of the litigation group. David Gindler's practice is almost entirely focused on patent disputes for life sciences companies. He is currently representing Genentech against more than a dozen IPR challengers seeking to clear the client's patents covering its blockbuster biologic Rituxan. In 2017, Gindler was named the California General Patent Litigator of the Year at the LMG Life Sciences Awards and is shortlisted in the same category this year. Jason Sheasby represents the firm's incoming generation of litigation talent and has quickly developed a name for himself in the legal market for his work in patent disputes.
Articles
Now accepting firm surveys and partner interviews